Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

IGF-1

Insulin-like Growth Factor 1, Somatomedin C

Quick Stats
Studies 92
Trials 100
Score 2
2025 pubmed

Evolution of Insulin, Insulin-like Growth Factor, and Their Cognate Receptors in Vertebrates, Invertebrates, and Viruses.

Chrudinová. Martina M; DaCosta. Jeffrey M JM; Dogru. Dogus D; Huang. Ruixu R; Reiners. Robert R; De Meyts. Pierre P; Altindis. Emrah E

Key Findings

  • IGF‑1 is the most conserved ligand across vertebrates, indicating a stable binding interface.
  • Insulin’s Site 2 residues vary, correlating with loss of hexamer formation in certain species.
  • Turtles have a 12‑amino‑acid insert in their insulin receptor previously thought unique to mammals.
  • Viral insulin/IGF‑like peptides split into two groups resembling either insulin or IGFs.

Practical Outcomes

  • For biohackers, the high conservation of IGF‑1 suggests that human IGF‑1 supplements are unlikely to have unexpected cross‑species effects, reinforcing its use as a stable growth factor. The variability in insulin’s structure warns that insulin analogs from other species may behave differently, so stick to well‑characterized human formulations. The viral peptide findings are mainly of academic interest and don’t change current supplementation protocols.

Summary

This study maps how insulin and IGF hormones and their receptors have changed over evolution. It shows that IGF‑1 is the most unchanged across animals, while insulin varies more, especially in parts that affect how it groups together. It also finds some surprising similarities in receptors of turtles and mammals, and that viruses make insulin‑like peptides that look like either insulin or IGF.

Abstract

The insulin and insulin-like growth factor (IGF) system regulates essential biological functions such as growth, metabolism, and development. While its physiological roles are well characterized, the evolutionary origins and molecular diversification of its ligands and receptors remain incompletely defined. Here, we present the most comprehensive phylogenetic and sequence conservation analysis of this system to date, using over 1,000 sequences from vertebrates, invertebrates, and viruses. Our analyses reveal that insulin, IGF-1, and IGF-2 form distinct monophyletic clades that diverged after the emergence of vertebrates, with IGF-1 being the most conserved ligand. We show that IGF1R-binding residues, especially in the A- and B-domains of IGF-1, are highly conserved across vertebrates, while insulin's Site 2 residues, which overlap with its dimerization and hexamerization surface, are more variable-correlating with the loss of hexamer formation in hystricomorphs, reptiles, and jawless fish. Unexpectedly, we identify a 12-amino acid insert in the insulin receptor (IR) of turtles and tortoises, previously thought to be unique to mammalian IR-B isoform, challenging the view that receptor isoform diversity is a mammalian innovation. We also show that marsupials and monotremes retain ancestral receptor domain features shared with reptiles and birds, and that avian insulins, particularly A-chain residues, are unusually conserved. Viral insulin/IGF-like peptides (VILPs) fall into two distinct clades that resemble either IGFs or insulin. Together, these findings illuminate the evolutionary architecture of the insulin/IGF system, highlight unexpected lineage-specific adaptations, and provide a framework for understanding hormone-receptor function across biology and therapeutic design.

Study Information

Provider

pubmed

Year

2025

Date

2025-12-08T00:00:00.000Z

DOI

10.1093/molbev/msaf319